Results 251 to 260 of about 12,137,319 (407)

Antibiofilm activity of a chionodracine‐derived peptide by NMR‐based metabolomics of cell‐free supernatant of Acinetobacter baumannii clinical strains

FEBS Open Bio, EarlyView.
KHS‐Cnd peptide is able to impair biofilm formation and disaggregate mature biofilms in Acinetobacter baumannii clinical isolates. Differences in extracellular metabolites reflect changes in biofilm metabolism due to KHS‐Cnd treatment. Among the differentially represented extracellular metabolites upon KHS‐Cnd treatment, the significantly altered ...
Fernando Porcelli, Enrico Landi, Francesco Maiurano, Irene Paris, Rosanna Papa, Marco Artini, Laura Selan, Stefano Borocci, Francesco Buonocore, Esther Imperlini   +9 more
wiley   +1 more source

Evaluation of myocardial fibrosis and cardiac function in fibrotic lung diseases: a prospective study. [PDF]

Sci Rep
Ekiz S, Esen K, Naycı S, Balcı Y, Yüksek HH.   +4 more
europepmc   +1 more source

Earthquake-Related Lung Diseases; A Bibliometric Analysis of Publications

Ege Güleç Balbay, Mehmet Nurullah Kurutkan, Pınar Yıldız Gülhan, Öner Balbay   +3 more
openalex   +2 more sources

Pathogenic Neurofibromatosis type 1 gene variants in tumors of non‐NF1 patients and role of R1276

FEBS Open Bio, EarlyView.
Somatic variants of the neurofibromatosis type 1 (NF1) gene occur across neoplasms without clinical manifestation of the disease NF1. We identified emerging somatic pathogenic NF1 variants and hotspots, for example, at the arginine finger 1276. Those missense variants provide fundamental information about neurofibromin's role in cancer.
Mareike Selig, Swanhild Lohse, Sara Elahi, Nils Hartmann, Stefanie Deckert, Shutian Si, Alexander Desuki, Anja Harder   +7 more
wiley   +1 more source

Computed tomography imaging features of major pulmonary and extrapulmonary complications of fibrotic lung diseases. [PDF]

Einstein (Sao Paulo)
Torres PPTES, Amaral PTMA, Hummel AD, Fonseca EKUN, Chate RC, Szarf G, Velasco FC, Escuissato DL, Rabahi MF, Marchiori E.   +9 more
europepmc   +1 more source

Lymphangioleiomyomatosis: diagnosis of a rare cystic lung disease in a clinical case

, 2023
M. A. Makarova, А. V. Chernyak
openalex   +2 more sources

Engineering tandem VHHs to target different epitopes to enhance antibody‐dependent cell‐mediated cytotoxicity

FEBS Open Bio, EarlyView.
Tandem VHH targeting distinct EGFR epitopes were engineered into a monovalent bispecific antibody (7D12‐EGA1‐Fc) with more potent ADCC without increasing affinity to EGFR. Structural modeling of 7D12‐EGA1‐Fc showed cross‐linking of separate EGFR domains to enhance CD16a engagement on NK cells.
Yuqiang Xu, Hao Jiang, Limin Chen, Fulai Zhou, Ying Jin, Mark L. Chiu   +5 more
wiley   +1 more source

Myeloid PDLIM2 repression as a common mechanism of infection susceptibility in lung diseases. [PDF]

Front Immunol
Gao F, Liu X, Sun F, Xiao Y, Xiao G, Qu Z.   +5 more
europepmc   +1 more source

FGFR Like1 drives esophageal cancer progression via EMT, PI3K/Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis

FEBS Open Bio, EarlyView.
Clinical analysis reveals significant dysregulation of FGFRL1 in esophageal cancer (EC) patients. RNAi‐coupled next‐generation sequencing (NGS) and in vitro study reveal FGFRL1‐mediated EC progression via EMT, PI3K/Akt, and Notch pathways. Functional assays confirm its role in tumor growth, migration, and invasion.
Aprajita Srivastava, Anoop Saraya, Deepak Gunjan, Rinu Sharma   +3 more
wiley   +1 more source

Interstitial lung diseases. [PDF]

Breathe (Sheff)
Sulaiman I.
europepmc   +1 more source